BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 20955559)

  • 1. NIR-emissive PEG-b-TCL micelles for breast tumor imaging and minimally invasive pharmacokinetic analysis.
    Hofmann CL; O'Sullivan MC; Detappe A; Yu Y; Yang X; Qi W; Landon CD; Therien MJ; Dewhirst MW; Ghoroghchian PP; Palmer GM
    Nanoscale; 2017 Sep; 9(36):13465-13476. PubMed ID: 28861570
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quantum-Dot-Based Theranostic Micelles Conjugated with an Anti-EGFR Nanobody for Triple-Negative Breast Cancer Therapy.
    Wang Y; Wang Y; Chen G; Li Y; Xu W; Gong S
    ACS Appl Mater Interfaces; 2017 Sep; 9(36):30297-30305. PubMed ID: 28845963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunomicelles: targeted pharmaceutical carriers for poorly soluble drugs.
    Torchilin VP; Lukyanov AN; Gao Z; Papahadjopoulos-Sternberg B
    Proc Natl Acad Sci U S A; 2003 May; 100(10):6039-44. PubMed ID: 12716967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel Lipid Nanocomplex Co-Carrying Bcl2 siRNA and Quantum Dots for EGF Receptor-Targeted Anti-Cancer Theranosis.
    Choi MJ; Kang SJ; Lee YK; Choi KC; Lee DH; Jeong HY; Kim MW; Kim KS; Park YS
    Int J Mol Sci; 2024 Jun; 25(11):. PubMed ID: 38892434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Migration of intradermally injected quantum dots to sentinel organs in mice.
    Gopee NV; Roberts DW; Webb P; Cozart CR; Siitonen PH; Warbritton AR; Yu WW; Colvin VL; Walker NJ; Howard PC
    Toxicol Sci; 2007 Jul; 98(1):249-57. PubMed ID: 17404394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantum dots targeted to vascular endothelial growth factor receptor 2 as a contrast agent for the detection of colorectal cancer.
    Carbary-Ganz JL; Barton JK; Utzinger U
    J Biomed Opt; 2014 Aug; 19(8):086003. PubMed ID: 25104409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro uptake of apoptotic body mimicking phosphatidylserine-quantum dot micelles by monocytic cell line.
    Maiseyeu A; Bagalkot V
    Nanoscale Res Lett; 2014; 9(1):176. PubMed ID: 24725273
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preparation of a nitric oxide imaging agent from gelatin derivative micelles.
    Tatsutomi M; Jo JI; Tabata Y
    Regen Ther; 2016 Dec; 5():64-71. PubMed ID: 31245503
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Correction to "Silica-Shelled Single Quantum Dot Micelles as Imaging Probes with Dual or Multimodality".
    Bakalova R; Zhelev Z; Aoki I; Ohba H; Imai Y; Kanno I
    Anal Chem; 2024 May; 96(18):7321. PubMed ID: 38680039
    [No Abstract]   [Full Text] [Related]  

  • 10. Quantum Dots: An Emerging Tool for Point-of-Care Testing.
    Singh S; Dhawan A; Karhana S; Bhat M; Dinda AK
    Micromachines (Basel); 2020 Nov; 11(12):. PubMed ID: 33260478
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Quantum dots-based tissue and in vivo imaging in breast cancer researches: current status and future perspectives.
    Wang LW; Peng CW; Chen C; Li Y
    Breast Cancer Res Treat; 2015 May; 151(1):7-17. PubMed ID: 25833213
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Imaging C-Fos Gene Expression in Burns Using Lipid Coated Spion Nanoparticles.
    Papagiannaros A; Righi V; Day GG; Rahme LG; Liu PK; Fischman AJ; Tompkins RG; Tzika AA
    Adv J Mol Imaging; 2012 Oct; 2(4):31-37. PubMed ID: 24995147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessing breast cancer margins ex vivo using aqueous quantum-dot-molecular probes.
    Au GH; Shih WY; Shih WH; Mejias L; Swami VK; Wasko K; Brooks AD
    Int J Surg Oncol; 2012; 2012():861257. PubMed ID: 23320158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoconjugates and long circulating systems: origins, current state of the art and future directions.
    Koshkaryev A; Sawant R; Deshpande M; Torchilin V
    Adv Drug Deliv Rev; 2013 Jan; 65(1):24-35. PubMed ID: 22964425
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Assembly and targeting of liposomal nanoparticles encapsulating quantum dots.
    Mukthavaram R; Wrasidlo W; Hall D; Kesari S; Makale M
    Bioconjug Chem; 2011 Aug; 22(8):1638-44. PubMed ID: 21786821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantum dot loaded immunomicelles for tumor imaging.
    Papagiannaros A; Upponi J; Hartner W; Mongayt D; Levchenko T; Torchilin V
    BMC Med Imaging; 2010 Oct; 10():22. PubMed ID: 20955559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced in vivo antitumor efficacy of poorly soluble PDT agent, meso-tetraphenylporphine, in PEG-PE-based tumor-targeted immunomicelles.
    Roby A; Erdogan S; Torchilin VP
    Cancer Biol Ther; 2007 Jul; 6(7):1136-42. PubMed ID: 17611407
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Photodynamic therapy of experimental B-16 melanoma in mice with tumor-targeted 5,10,15,20-tetraphenylporphin-loaded PEG-PE micelles.
    Skidan I; Dholakia P; Torchilin V
    J Drug Target; 2008 Jul; 16(6):486-93. PubMed ID: 18604661
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantum dots encapsulated in phospholipid micelles for imaging and quantification of tumors in the near-infrared region.
    Papagiannaros A; Levchenko T; Hartner W; Mongayt D; Torchilin V
    Nanomedicine; 2009 Jun; 5(2):216-24. PubMed ID: 19223245
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.